TrianglePUBLICATIONS · 34301810
First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Immunother Cancer
- Publication date
- 2021 Jul
- First author
- D'Angelo SP
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- D'Angelo SP
- type
- Author
- name
- Lebbé C
- type
- Author
- name
- Mortier L
- type
- Author
- name
- Brohl AS
- type
- Author
- name
- Fazio N
- type
- Author
- name
- Grob JJ
- type
- Author
- name
- Prinzi N
- type
- Author
- name
- Hanna GJ
- type
- Author
- name
- Hassel JC
- type
- Author
- name
- Kiecker F
- type
- Author
- name
- Georges S
- type
- Author
- name
- Ellers-Lenz B
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- D'Angelo SP
- type
- Author
- name
- Lebbé C
- type
- Author
- name
- Mortier L
- type
- Author
- name
- Brohl AS
- type
- Author
- name
- Fazio N
- type
- Author
- name
- Grob JJ
- type
- Author
- name
- Prinzi N
- type
- Author
- name
- Hanna GJ
- type
- Author
- name
- Hassel JC
- type
- Author
- name
- Kiecker F
- type
- Author
- name
- Georges S
- type
- Author
- name
- Ellers-Lenz B
- type
- Author
- bibliography ids
- nci-bib-1655b55c8beada62ed41518a
- book metadata
- content sha256
- f4db905a9aa42815aabfb4fb88795ad9ee3b311100fa756093e128f0e7866d85
- document type
- citation
- dois
- 10.1136/jitc-2021-002646
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34301810
- immutable id
- pubmed:34301810@f4db905a9aa42815aabfb4fb88795ad9ee3b311100fa756093e128f0e7866d85
- journal
- abbreviation
- J Immunother Cancer
- issn electronic
- 2051-1426
- issn print
- Source null
- issue
- 7
- name
- Journal for immunotherapy of cancer
- nlm unique id
- 101620585
- pages
- Source null
- volume
- 9
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34301810
- provenance
- batch id
- 192b6392c165c6b06274
- provider
- NCBI PubMed ESummary
- record sha256
- 9d5b317fc5d9418c8a7b356de7f8ad965e73f704ca97bc3ceb31a3e3fdff4a26
- response sha256
- 7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
- retrieved at
- 2026-09-09T23:48:02.713075+00:00
- publication date
- display
- 2021 Jul
- precision
- month
- year
- 2021
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study.
Preserved source evidence · Not medical advice